Results 251 to 260 of about 194,263 (372)

Performance of the Monoclonal Antibody B72.3 in Diagnosis of Malignant Carcinomatous Serous Effusions—A Systematic Review and Meta‐Analysis of Diagnostic Performance

open access: yesCytopathology, EarlyView.
B72.3 is a carcinoma marker with an acceptable performance but relatively low sensitivity. With its specificity, B72.3 may find use in an immunocytochemical panel for excluding benign mesothelial processes. ABSTRACT Objectives Immunocytochemistry is often required in the cytologic assessment of malignant serous effusion, particularly for ...
Alex H. Lin   +9 more
wiley   +1 more source

Stoking fears of AI X-Risk (while forgetting justice here and now). [PDF]

open access: yesJ Med Ethics
Jecker NS   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy